Bachelor of Biomedicine

University of Tasmania

Type of institution: University/Higher Education Institution
Level: Undergraduate
CRICOS: 00586B

Hands-on learning from researchers actively connected to the healthcare sector Our biomedicine course is designed and taught by active medical researchers at the Tasmanian School of Medicine and the School of Health Sciences. It also draws on the expertise of our specialist research and teaching institutes: the Menzies Institute for Medical Research, and the Wicking Dementia Research and Education Centre. As the single university for Tasmania, we provide unparalleled access and connection to the local community, health system, and institutes. This means that throughout your studies you are learning from experts who are directly engaged with the health sector both locally, nationally, and internationally. We also provide access to the global knowledgebase of research groups, institutes, and organizations through our ongoing collaborations and research.

Structure

The Bachelor of Biomedicine requires the completion of 300 credit points

Standard entry requirements

  • The minimum ATAR for this course is 75.
  • Applicants are ranked by ATAR and offers are made based on the number of places available. In 2024, the lowest ATAR to receive an offer into this course was 75.7. The lowest ATAR to receive an offer may change from year to year based on the number of applications we receive.

Study information

CampusFeesEntryMid year intakeAttendance
Hobart International: $119,757 No
  • Full-time : 3 years
  • Part-time : 7 years
Launceston International: $119,757 No
  • Full-time : 3 years
  • Part-time : 7 years

Fee comments

Campuses: Hobart, Launceston.

Also available for Domestic, Please Contact University of Tasmania for more information about tuition fees.

Related courses

Browse more courses
Is the information on this page correct? Request update
Enquire about this course
You must agree before submitting.

Become a member

Already a member? LoginForgot password?

Join the conversation